The MisoPROM study: A multicenter randomized comparison of oral misoprostol and oxytocin for premature rupture of membranes at term

American Journal of Obstetrics and Gynecology

Volumn 189, Issue 4, 2003, Pages 1026-1030

  Mozurkewich, Ellen ^a   Horrocks, Julie ^a   Daley, Suzanne ^a   Von Oeyen, Paul ^b   Halvorson, Melissa ^c   Johnson, Mary ^d   Zaretsky, Michael ^e   Tehranifar, Mitra ^f   Bayer Zwirello, Lucy ^g   Robichaux III, Alfred ^h   Droste, Sabine ⁱ   Turner, Garry ^j  

^a UNIVERSITY OF MICHIGAN HEALTH SYSTEM   (United States)

^b WILLIAM BEAUMONT HOSPITAL   (United States)

^c Spectrum Hospital Downtown   (United States)

^d S Joseph Mercy Medical Center   (United States)

^e BAYLOR UNIVERSITY MEDICAL CENTER   (United States)

^f UNIVERSITY OF NEW MEXICO HEALTH SCIENCES CENTER   (United States)

^g Bay State Medical Center   (United States)

^h Woman's Hospital   (United States)

ⁱ UNIVERSITY OF WISCONSIN MADISON   (United States)

^j NEW BRITAIN GENERAL HOSPITAL   (United States)

more..

Author keywords

Misoprostol; Oxytocin; Premature rupture of membranes

Indexed keywords

MISOPROSTOL; OXYTOCIN;

ADULT; ANTIBIOTIC THERAPY; ARTICLE; CESAREAN SECTION; CHORIOAMNIONITIS; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFICACY; FEMALE; HUMAN; LABOR INDUCTION; MAJOR CLINICAL STUDY; MULTICENTER STUDY; NEWBORN INFECTION; NEWBORN PERIOD; NULLIPARA; POSTPARTUM HEMORRHAGE; PREMATURE FETUS MEMBRANE RUPTURE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RISK; VAGINAL DELIVERY;

EID: 0242425742     PISSN: 00029378     EISSN: None     Source Type: Journal    
DOI: 10.1067/S0002-9378(03)00845-7     Document Type: Article

References (9)

1. Sanchez-Ramos L, Kaunitz AM, Wears RL, Delke I, Gaudier FL. Misoprostol for cervical ripening and labor induction: a meta-analysis. Obstet Gynecol 1997;89:633-42.
2. Sanchez-Ramos L, Kaunitz AM. Misoprostol for cervical ripening and labor induction: a systematic review of the literature. Clin Obstet Gynecol 2000;43:475-88.
3. Butt KD, Bennett KA, Crane JM, Hutchens D, Young DC. Randomized comparison of oral misoprostol and oxytocin for labor induction in term prelabor membrane rupture. Obstet Gynecol 1999;94:994-9.
4. Ngai SW, Chan YM, Lam SW, Lao TT. Labour characteristics and uterine activity: Misoprostol compared with oxytocin in women at term with prelabour rupture of the membranes. BJOG 2000;107:222-7.
5. Hannah ME, Ohlsson A, Farine D, Hewson SA, Hodnett ED, Myhr TL, et al. Induction of labor compared with expectant management for prelabor rupture of the membranes at term: Term PROM Study Group. N Engl J Med 1996;334:1005-10.
6. Hannah ME. Prelabor rupture of membranes at term. N Engl J Med 1996;335:1156-9.
7. Hayashi RH. Postpartum hemorrhage and puerperal sepsis. In: Hacker NF, Moore JG. Essentials of obstetrics and gynecology. Philadelphia: WB Saunders; 1998. p. 333-42.
8. Cullen M. Important drug warning concerning unapproved use of intravaginal or oral misoprostol in pregnant women for induction of labor or abortion. Skokie (IL): Searle; 2000.
9. Jennison C, Turnbull BW. Statistical approaches to interim monitoring of medical trials: a review and commentary. Stat Sci 1990;5:299-317.